Target intelligence / Profile preview

Zinc finger protein 114 (ZNF114)

Target
ZNF114
Molecular classification
Transcription factor, Zinc finger protein (specifically C2H2-type, the most common family in humans)
01

Overview

Zinc finger protein 114 (ZNF114) is a member of the C2H2-type zinc finger protein family, which constitutes one of the most abundant groups of transcription factors in the human genome. These proteins contain characteristic zinc finger domains that coordinate a zinc ion with cysteine and histidine residues, enabling them to bind DNA and regulate gene transcription. ZNF114 is believed to function primarily as a transcriptional regulator, influencing the expression of target genes involved in cell development, differentiation, proliferation, and apoptosis. The broad ZNF family is implicated in processes such as chromatin remodeling and cell signaling and has disease relevance for cancer, neurodegeneration, and other conditions, although direct evidence for ZNF114’s involvement in a specific pathology is lacking. There are currently no drugs, biomarkers, or safety concerns directly attributed to ZNF114, and it is not considered a canonical therapeutic target.

Other names
ZNF114MGC17986Zinc finger protein 114 (Y18)
02

Mechanism of action

Not applicable; no drugs known to target ZNF114.

03

Biological functions

Transcriptional regulation (regulates gene expression by binding DNA)DNA bindingCellular differentiation and development (general role of many ZNFs)Regulation of cell proliferation and apoptosis (as shown for some family members)
04

Disease associations

Indirect association with cancer (many ZNFs implicated in cancer; specific roles for ZNF114 have not been firmly established)Possible involvement in other diseases common to ZNF family such as neurodegeneration, diabetes, and skin diseaseDirect, specific disease associations for ZNF114 are not well-documented
05

Safety considerations

None documented; not associated with therapeutic interventions.
06

Interacting drugs

None known or documented; ZNF114 has not been identified as a direct drug target.
07

Biomarkers

None known for ZNF114; it is not used as a biomarker in clinical settings.

Beyond the preview

Go deeper on Zinc finger protein 114 (ZNF114).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 114 (ZNF114).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call